Volume 156, Issue 6, Pages (December 1996)

Slides:



Advertisements
Similar presentations
UvrD Helicase Unwinds DNA One Base Pair at a Time by a Two-Part Power Stroke Jae Young Lee, Wei Yang Cell Volume 127, Issue 7, Pages (December.
Advertisements

Eph-Ephrin Bidirectional Signaling in Physiology and Disease Elena B. Pasquale Cell Volume 133, Issue 1, Pages (April 2008) DOI: /j.cell
Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.
A Hydrodynamic Model for Hindered Diffusion of Proteins and Micelles in Hydrogels Ronald J. Phillips Biophysical Journal Volume 79, Issue 6, Pages
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT.
How surgeons can find information online? Martin Hewitt International Journal of Surgery Volume 5, Issue 6, Pages (December 2007) DOI: /j.ijsu
The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.
Peopling of Sahul: mtDNA Variation in Aboriginal Australian and Papua New Guinean Populations Alan J. Redd, Mark Stoneking The American Journal of Human.
Enhancing the value of orthodontic treatment: Incorporating effective preventive dentistry into treatment  Robert L. Boyda  American Journal of Orthodontics.
A Tablet for Healthy Ageing: The Effect of a Tablet Computer Training Intervention on Cognitive Abilities in Older Adults  Eleftheria Vaportzis, Ph.D.,
592 PATIENT COMPLIANCE AND OUTCOMES IN BOWEL AND BLADDER DYSFUNCTION TREATED WITH PELVIC FLOOR PHYSICAL THERAPY  Zachary Liss, Bryan Roelof, Theodore.
MP60-03 PROSTATE CANCER IN THE ELDERLY
Hematocrit Response and Risk Factors for Significant Hematocrit Elevation with Implantable Testosterone Pellets  Russell P. Hayden, Nelson E. Bennett,
Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men
National Guidelines for Nursing Delegation
Benjamin Herrick, Cameron Banga, Michael Phelps, Ronald Yap 
Hyperbaric Oxygenation in Cardiac and Pulmonary Disease
Airway obstruction in never smokers: Results from the Third National Health and Nutrition Examination Survey  Bartolome R. Celli, MD, R.J. Halbert, MD,
Effect of antibacterials on biofilms
The Male Factor in Fertility and Infertility. II
Volume 187, Issue 4, Pages e515-e516 (April 2012)
Primary Small Cell Carcinoma Arising from a Bladder Diverticulum
Bladder Lymphoma The Journal of Urology
Richard V. Milani, MD, Carl J. Lavie, MD, Robert M
Seminal Vesicle Invasion by Adenocarcinoma of the Prostate
Oncocytoma of the Kidney
Paratesticular Serous Papillary Borderline Tumor
Volume 189, Issue 1, Pages (January 2013)
Pseudohyperplastic Adenocarcinoma of the Prostate
Using Animated Computer-generated Text and Graphics to Depict the Risks and Benefits of Medical Treatment  Alan R. Tait, PhD, Terri Voepel-Lewis, MSN,
Robert Goulden, MBBS, MSc, MPhil, MA  The American Journal of Medicine 
Quiz page American Journal of Kidney Diseases
Gout in African Americans
Evaluation of the Potential Living Kidney Donor
Salt and Hypertension American Journal of Kidney Diseases
This Month in AJKD American Journal of Kidney Diseases
European Urology is “Your” Journal
Barry Marshall 2005 Nobel Laureate in Medicine and Physiology
A Futile Approach to Fighting Obesity?
Quiz page December 2004 American Journal of Kidney Diseases
Minutes of the Board of Directors Meeting
Erratum The American Journal of Human Genetics
Volume 143, Issue 6, (December 2010)
Christina L. Klein, MD, Daniel C. Brennan, MD, FACP 
Quiz Page April 2008 American Journal of Kidney Diseases
Journal of Investigative Dermatology 
Bedside Calibration Of Pulmonary Artery Catheters
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Erratum American Journal of Kidney Diseases
Table of contents The Journal for Nurse Practitioners
Society for Investigative Dermatology 2010 Meeting Minutes
Position of the American Dietetic Association: Vegetarian Diets
Research Snippets Journal of Investigative Dermatology
Reviewer Acknowledgment
Research Snippets from the British Journal of Dermatology
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Table of contents The Journal for Nurse Practitioners
Journal of Investigative Dermatology
This Month in AJKD American Journal of Kidney Diseases
This Month in AJKD American Journal of Kidney Diseases
Erratum American Journal of Kidney Diseases
This Month in AJKD American Journal of Kidney Diseases
Discussion The Journal of Thoracic and Cardiovascular Surgery
Journal of Investigative Dermatology
Journal of the American College of Surgeons
Quiz Page January 2010 American Journal of Kidney Diseases
Quiz page December 2003 American Journal of Kidney Diseases
This Month in AJKD American Journal of Kidney Diseases
The Size Distribution of Homozygous Segments in the Human Genome
Presentation transcript:

Volume 156, Issue 6, Pages 2084-2088 (December 1996) Effects of Tadenan Pretreatment on Bladder Physiology and Biochemistry Following Partial Outlet Obstruction  Robert M. Levin, J.-P. Riffaud, F. Bellamy, Dorothea Rohrmann, Lev Krasnopolsky, Niels Haugaard, Yang Zhao, Alan J. Wein  The Journal of Urology  Volume 156, Issue 6, Pages 2084-2088 (December 1996) DOI: 10.1016/S0022-5347(01)65440-5 Copyright © 1996 American Urological Association, Inc. Terms and Conditions

Figure 1 Effect of Tadenan on bladder weight. Each bar is mean plus/minus standard error of mean of 5 individual preparations (animals). * = significantly different from control. The Journal of Urology 1996 156, 2084-2088DOI: (10.1016/S0022-5347(01)65440-5) Copyright © 1996 American Urological Association, Inc. Terms and Conditions

Figure 2 Effect of Tadenan on response to field stimulation. Each bar is the mean plus/minus standard error of mean of 5 individual preparations (animals). * = significantly different from control. X = significantly different from Tadenan treated. (p less than 0.05). The Journal of Urology 1996 156, 2084-2088DOI: (10.1016/S0022-5347(01)65440-5) Copyright © 1996 American Urological Association, Inc. Terms and Conditions

Figure 3 Effect of Tadenan on response to bethanechol. Each bar is the mean plus/minus standard error of mean of 5 individual preparations (animals). * = significantly different from control. X = significantly different from Tadenan treated. (p less than 0.05). The Journal of Urology 1996 156, 2084-2088DOI: (10.1016/S0022-5347(01)65440-5) Copyright © 1996 American Urological Association, Inc. Terms and Conditions

Figure 4 Effect of Tadenan on response to KCl. Each bar is the mean plus/minus standard error of mean of 5 individual preparations (animals). * = significantly different from control. X = significantly different from Tadenan treated. (p less than 0.05). The Journal of Urology 1996 156, 2084-2088DOI: (10.1016/S0022-5347(01)65440-5) Copyright © 1996 American Urological Association, Inc. Terms and Conditions

Figure 5 Effect of Tadenan on response to ATP. Each bar is the mean plus/minus standard error of mean of 5 individual preparations (animals). * = significantly different from control. X = significantly different from Tadenan treated. (p less than 0.05). The Journal of Urology 1996 156, 2084-2088DOI: (10.1016/S0022-5347(01)65440-5) Copyright © 1996 American Urological Association, Inc. Terms and Conditions

Figure 6 Effect of Tadenan citrate synthase activity. Each bar is the mean plus/minus standard error of mean of 5 individual preparations (animals). * = significantly different from control. X = significantly different from Tadenan treated. (p less than 0.05). The Journal of Urology 1996 156, 2084-2088DOI: (10.1016/S0022-5347(01)65440-5) Copyright © 1996 American Urological Association, Inc. Terms and Conditions

Figure 7 Effect of Tadenan on calcium ATP'ase activity. Each bar is the mean plus/minus standard error of mean of 5 individual preparations (animals). * = significantly different from control. X = significantly different from Tadenan treated. (p less than 0.05). The Journal of Urology 1996 156, 2084-2088DOI: (10.1016/S0022-5347(01)65440-5) Copyright © 1996 American Urological Association, Inc. Terms and Conditions